Literature DB >> 1244549

Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes.

M E Levin, V C Boisseau, L V Avioli.   

Abstract

To assess the influence of diabetes mellitus on bone metabolism, we measured skeletal mass in the forearms of 35 patients with juvenile diabetes on insulin and 101 stable patients with adult-onset diabetes, on diet alone, insulin, or oral hypoglycemic agents. There was a significant loss of bone mass in both juvenile and adult-onset diabetes (P less than 0.01) as compared to controls matched for age and sex. The decrease was already present in patients with diabetes of less than five years' duration. Bone loss and duration of the diabetes did not correlate; the greatest decrease in bone mass was observed in the patients receiving oral agents. These data are consistent with the hypothesis that the loss of skeletal tissue in diabetes reflects the underlying disease since it occurs early and is not related to severity as evidenced by the need for insulin, to duration, or to treatment with insulin or diet alone.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1244549     DOI: 10.1056/NEJM197601292940502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  102 in total

1.  Effect of insulin on the incorporation of citrate and calcium into the bones of alloxan-diabetic rats.

Authors:  P K Dixit; A M Stern
Journal:  Calcif Tissue Int       Date:  1979-07-03       Impact factor: 4.333

2.  The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.

Authors:  Yasuhiro Hamada; Sohei Kitazawa; Riko Kitazawa; Keiji Kono; Shunsuke Goto; Hirotaka Komaba; Hideki Fujii; Yasuhiko Yamamoto; Hiroshi Yamamoto; Makoto Usami; Masafumi Fukagawa
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

3.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

4.  Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.

Authors:  T Shibata; S Takeuchi; S Yokota; K Kakimoto; F Yonemori; K Wakitani
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

5.  Effect of targeted delivery of bone morphogenetic protein-2 on bone formation in type 1 diabetes.

Authors:  Ronaldo Barcellos de Santana; Phillip C Trackman
Journal:  Int J Oral Maxillofac Implants       Date:  2015 May-Jun       Impact factor: 2.804

6.  Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway.

Authors:  M Inaba; Y Nishizawa; A Shioi; H Morii
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

7.  Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells.

Authors:  A D McCarthy; S B Etcheverry; L Bruzzone; A M Cortizo
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

8.  Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications.

Authors:  P Pietschmann; G Schernthaner; W Woloszczuk
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

Review 9.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

10.  Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats.

Authors:  Y Fong; D Edelstein; E A Wang; M Brownlee
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.